Publicaciones
Análisis Clínicos
BRAF inhibition by vemurafenib in combination with temozolomide or fotemustine in melanoma cells.
Publicado en: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (Vol. 14, pp. 27-27).
Análisis Clínicos
Temporal and mechanistic studies on the resistance of glioma cells to temozolomide.
Publicado en: Klinische Pädiatrie, 228(06/07), A14
Análisis Clínicos
Biocomputing platform module for cancer genomics and chemotherapy
Publicado en: In Central American and Panama Convention (CONCAPAN XXXVI), 2016 IEEE 36th (pp. 1-6). IEEE.
Análisis Clínicos
The influence of the TCM drug artesunate on the sensitivity of tumor cell lines and his cytotoxic an genotoxic activity.
Publicado en: In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (Vol. 383, pp. 101-101)
Análisis Clínicos
Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells
Publicado en: Molecular cancer therapeutics, 10(12), 2224-2233.